Winner Medical Co., Ltd. (SHE: 300888)
China
· Delayed Price · Currency is CNY 32.15
+0.05 (0.16%)
Nov 15, 2024, 3:04 PM CST
Winner Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 8,184 | 8,124 | 11,258 | 7,976 | 12,438 | 4,512 | Upgrade
|
| Other Revenue | 60.7 | 60.7 | 93.58 | 61.2 | 96.17 | 62.27 | Upgrade
|
| Revenue | 8,245 | 8,185 | 11,351 | 8,037 | 12,534 | 4,575 | Upgrade
|
| Revenue Growth (YoY) | -15.17% | -27.89% | 41.23% | -35.87% | 173.99% | 19.16% | Upgrade
|
| Cost of Revenue | 4,546 | 4,393 | 6,340 | 4,121 | 5,212 | 2,240 | Upgrade
|
| Gross Profit | 3,699 | 3,792 | 5,011 | 3,916 | 7,322 | 2,335 | Upgrade
|
| Selling, General & Admin | 2,924 | 2,756 | 2,649 | 2,444 | 2,012 | 1,547 | Upgrade
|
| Research & Development | 284.84 | 322.05 | 487.58 | 298.16 | 411.38 | 155.19 | Upgrade
|
| Other Operating Expenses | 61.18 | 39.96 | 98.09 | 65.39 | 116.57 | 39.55 | Upgrade
|
| Operating Expenses | 3,274 | 3,115 | 3,229 | 2,804 | 2,563 | 1,741 | Upgrade
|
| Operating Income | 424.24 | 677.12 | 1,782 | 1,113 | 4,759 | 593.99 | Upgrade
|
| Interest Expense | -52.71 | -63.44 | -50.04 | -29.99 | -3.61 | -12.45 | Upgrade
|
| Interest & Investment Income | 220.51 | 261.26 | 175.38 | 240.42 | 44.93 | 1.89 | Upgrade
|
| Currency Exchange Gain (Loss) | -7.63 | -7.63 | 52.07 | 0.61 | -239.43 | 3.62 | Upgrade
|
| Other Non Operating Income (Expenses) | -21.83 | 0.68 | -72.25 | -4.27 | -12.37 | -25.38 | Upgrade
|
| EBT Excluding Unusual Items | 562.59 | 867.99 | 1,887 | 1,319 | 4,549 | 561.67 | Upgrade
|
| Impairment of Goodwill | -188.79 | -188.79 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -10.15 | 46.68 | 32.15 | 58.47 | 11.18 | -2.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1,567 | 32.2 | 3.73 | 3.25 | 0.01 | 61.68 | Upgrade
|
| Asset Writedown | -5.27 | -93.43 | -74.78 | -20.26 | -124.55 | -7.97 | Upgrade
|
| Other Unusual Items | 85.19 | 85.19 | 71.05 | 101.8 | 66.94 | 25.74 | Upgrade
|
| Pretax Income | -1,123 | 749.85 | 1,920 | 1,463 | 4,502 | 638.41 | Upgrade
|
| Income Tax Expense | -152.12 | 121.3 | 245.17 | 225.32 | 679.91 | 91.21 | Upgrade
|
| Earnings From Continuing Operations | -971.19 | 628.55 | 1,674 | 1,237 | 3,823 | 547.2 | Upgrade
|
| Minority Interest in Earnings | -43.21 | -48.14 | -23.62 | 1.88 | -12.14 | -0.91 | Upgrade
|
| Net Income | -1,014 | 580.4 | 1,651 | 1,239 | 3,810 | 546.29 | Upgrade
|
| Net Income to Common | -1,014 | 580.4 | 1,651 | 1,239 | 3,810 | 546.29 | Upgrade
|
| Net Income Growth | - | -64.84% | 33.20% | -67.48% | 597.50% | 28.64% | Upgrade
|
| Shares Outstanding (Basic) | 587 | 592 | 592 | 596 | 544 | 527 | Upgrade
|
| Shares Outstanding (Diluted) | 587 | 592 | 592 | 596 | 545 | 527 | Upgrade
|
| Shares Change (YoY) | -0.54% | 0.10% | -0.77% | 9.42% | 3.31% | 1.14% | Upgrade
|
| EPS (Basic) | -1.73 | 0.98 | 2.79 | 2.08 | 7.00 | 1.04 | Upgrade
|
| EPS (Diluted) | -1.73 | 0.98 | 2.79 | 2.08 | 6.99 | 1.04 | Upgrade
|
| EPS Growth | - | -64.87% | 34.22% | -70.28% | 575.19% | 27.19% | Upgrade
|
| Free Cash Flow | 492.28 | 310.26 | 1,784 | 128.42 | 4,194 | 152.87 | Upgrade
|
| Free Cash Flow Per Share | 0.84 | 0.52 | 3.02 | 0.22 | 7.70 | 0.29 | Upgrade
|
| Dividend Per Share | 0.900 | 0.500 | 1.357 | 0.900 | 1.800 | - | Upgrade
|
| Dividend Growth | -33.68% | -63.16% | 50.79% | -50.00% | - | - | Upgrade
|
| Gross Margin | 44.86% | 46.33% | 44.15% | 48.73% | 58.42% | 51.04% | Upgrade
|
| Operating Margin | 5.15% | 8.27% | 15.70% | 13.84% | 37.97% | 12.98% | Upgrade
|
| Profit Margin | -12.30% | 7.09% | 14.54% | 15.42% | 30.40% | 11.94% | Upgrade
|
| Free Cash Flow Margin | 5.97% | 3.79% | 15.72% | 1.60% | 33.46% | 3.34% | Upgrade
|
| EBITDA | 766.7 | 987.02 | 2,049 | 1,279 | 4,918 | 697.42 | Upgrade
|
| EBITDA Margin | 9.30% | 12.06% | 18.05% | 15.92% | 39.24% | 15.25% | Upgrade
|
| D&A For EBITDA | 342.46 | 309.9 | 266.49 | 166.69 | 158.62 | 103.43 | Upgrade
|
| EBIT | 424.24 | 677.12 | 1,782 | 1,113 | 4,759 | 593.99 | Upgrade
|
| EBIT Margin | 5.15% | 8.27% | 15.70% | 13.84% | 37.97% | 12.98% | Upgrade
|
| Effective Tax Rate | - | 16.18% | 12.77% | 15.40% | 15.10% | 14.29% | Upgrade
|
| Revenue as Reported | 8,245 | 8,185 | 11,351 | 8,037 | 12,534 | 4,575 | Upgrade
|
| Advertising Expenses | - | 651.82 | 600.16 | 692.45 | 372.94 | 268.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.